Mia's Feed
Medical News & Research

Harnessing AI Chatbots to Support Pregnant Women with Opioid Use Disorder

Harnessing AI Chatbots to Support Pregnant Women with Opioid Use Disorder

Share this article

2 min read

Recent research highlights the promising role of AI chatbots in assisting pregnant women dealing with opioid use disorder (OUD). The stigma often associated with addiction discourages many expectant mothers from seeking help, facing judgment or unsupportive responses from healthcare providers and loved ones. Drew Herbert, a doctoral student at the University of Missouri Sinclair School of Nursing and experienced nurse, emphasized that conversations about opioid use can be tough, with women frequently told to simply quit or consider their baby's health, which may overlook the complexities of addiction and withdrawal risks.

Acknowledging that some individuals feel more comfortable consulting anonymous online platforms, Herbert explored whether GPT-4, a sophisticated language model, could be ethically and safely employed to provide empathetic, accurate, and supportive guidance for pregnant women with OUD. His team developed a proof-of-concept where GPT-4, named 'Jade', was prompted with a scenario of a pregnant woman seeking help to quit opioids.

The chatbot responded with gratitude and encouragement, then offered evidence-based options such as medication-assisted treatment with buprenorphine, which helps manage cravings and withdrawal symptoms—crucial for creating a safer pregnancy environment. Using motivational interviewing techniques, the AI aimed to empower women rather than simply instruct them, aligning with best practices in addiction counseling.

When asked about local treatment options, Jade provided lists of clinics, telemedicine providers, and reputable directories like SAMHSA and ASAM. The responses, evaluated by experienced clinicians, were deemed safe, accurate, and highly relevant in over 96% of cases.

Herbert envisions this technology as a valuable supplement to existing healthcare, especially amid clinician shortages, where it can serve as a first point of contact, disseminate trustworthy information, and guide users towards professional help. He plans to refine the chatbot further, incorporating feedback from clinicians and women with lived experience. Ultimately, this approach aims to democratize access to reliable treatment information, reduce barriers to care, and support healthier pregnancies.

This innovative work was published in the Journal of Studies on Alcohol and Drugs (2025). Source: https://medicalxpress.com/news/2025-05-ai-chatbots-pregnant-women-opioid.html

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Research Finds Hepatitis B Immunity May Reduce Diabetes Risk

A new study reveals that immunity to hepatitis B virus, achieved through vaccination, may decrease the risk of developing diabetes, especially among younger adults. This discovery suggests additional health benefits of HBV vaccination beyond infection prevention.

Understanding Mohs Micrographic Surgery: FAQs and Insights

Learn about Mohs micrographic surgery, a highly effective skin cancer treatment that offers precise removal with minimal tissue loss and high cure rates. Discover its benefits, suitable cancers, procedure details, recovery, and prevention tips.

Understanding Chikungunya Virus: Risks and Precautions for Australia

Learn about the spread of chikungunya virus, its symptoms, how it transmits, and what travelers to Australia need to know to stay safe against this mosquito-borne disease.

Managing Antihypertensive Medications Around Non-Cardiac Surgery to Improve Outcomes

Emerging evidence suggests that continuing ACE inhibitors and ARBs before and after non-cardiac surgery can reduce postoperative mortality and functional decline, improving patient outcomes.